{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T17:18:10Z","timestamp":1771953490060,"version":"3.50.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T00:00:00Z","timestamp":1763596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T00:00:00Z","timestamp":1763596800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100007128","name":"Natural Science Foundation of Shaanxi Province","doi-asserted-by":"crossref","award":["(2025JC-YBMS-934, 2025JC-YBMS-963)"],"award-info":[{"award-number":["(2025JC-YBMS-934, 2025JC-YBMS-963)"]}],"id":[{"id":"10.13039\/501100007128","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Key Scientific Research Program of Shaanxi Provincial Department of Education","award":["(23JS013)"],"award-info":[{"award-number":["(23JS013)"]}]},{"name":"Key Discipline Construction Project of High - level Traditional Chinese Medicine in Nursing of Shaanxi University of Chinese Medicine","award":["(2024XKZD16)"],"award-info":[{"award-number":["(2024XKZD16)"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["Grant No. 82500220"],"award-info":[{"award-number":["Grant No. 82500220"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"DOI":"10.1007\/s12032-025-03128-y","type":"journal-article","created":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T02:14:34Z","timestamp":1763604874000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Network pharmacology, molecular docking, and experimental validation-based approach to explore the mechanism of action of ginsenoside Rh4 on acute myeloid leukemia cells"],"prefix":"10.1007","volume":"43","author":[{"given":"Xin","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pei","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuting","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin-kun","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fengjiao","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,20]]},"reference":[{"issue":"4","key":"3128_CR1","doi-asserted-by":"publisher","first-page":"189377","DOI":"10.1016\/j.bbcan.2025.189377","volume":"1880","author":"DL Barry","year":"2025","unstructured":"Barry DL, Enjeti AK, Lincz LF, et al. Combination therapy in cancer: the potential of tetrandrine as a polytherapy for acute myeloid leukemia. Biochim Biophys Acta Rev Cancer. 2025;1880(4):189377. https:\/\/doi.org\/10.1016\/j.bbcan.2025.189377.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"3128_CR2","doi-asserted-by":"publisher","first-page":"117999","DOI":"10.1016\/j.biopha.2025.117999","volume":"186","author":"L Yang","year":"2025","unstructured":"Yang L, Chen Y, Wu Y, et al. The hypoxia signaling pathway in the development of acute myeloid leukemia. Biomed Pharmacother. 2025;186:117999. https:\/\/doi.org\/10.1016\/j.biopha.2025.117999.","journal-title":"Biomed Pharmacother"},{"key":"3128_CR3","doi-asserted-by":"publisher","first-page":"117174","DOI":"10.1016\/j.bcp.2025.117174","volume":"229","author":"G Tu","year":"2025","unstructured":"Tu G, Wu Q, Yuan Y, et al. DNA damage agents trigger iNKT cell-mediated elimination of AML cells through activation of NF-\u03baB\/HLA-DRB6\/CD1d pathway. Biochem Pharmacol. 2025;229:117174. https:\/\/doi.org\/10.1016\/j.bcp.2025.117174.","journal-title":"Biochem Pharmacol"},{"issue":"3","key":"3128_CR4","doi-asserted-by":"publisher","first-page":"e0325937","DOI":"10.1371\/journal.pone.0325937","volume":"20","author":"C Hu","year":"2025","unstructured":"Hu C, Chen W, Zhang P, et al. Global, regional, and National burden of leukemia: epidemiological trends analysis from 1990 to 2021. PLoS ONE. 2025;20(3):e0325937. https:\/\/doi.org\/10.1371\/journal.pone.0325937.","journal-title":"PLoS ONE"},{"issue":"1","key":"3128_CR5","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s40364-024-00649-y","volume":"12","author":"Y Zhou","year":"2024","unstructured":"Zhou Y, Huang G, Cai X, et al. Global, regional, and National burden of acute myeloid leukemia, 1990\u20132021: a systematic analysis for the global burden of disease study 2021. Biomark Res. 2024;12(1):101. https:\/\/doi.org\/10.1186\/s40364-024-00649-y.","journal-title":"Biomark Res"},{"issue":"1","key":"3128_CR6","doi-asserted-by":"publisher","first-page":"46","DOI":"10.3322\/caac.21873","volume":"75","author":"HM Kantarjian","year":"2025","unstructured":"Kantarjian HM, DiNardo CD, Kadia TM, et al. Acute myeloid leukemia management and research in 2025. CA Cancer J Clin. 2025;75(1):46\u201367. https:\/\/doi.org\/10.3322\/caac.21873.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"3128_CR7","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1186\/s13046-025-03420-9","volume":"44","author":"X Ma","year":"2025","unstructured":"Ma X, Li Y, Wang D, et al. PSMB10 maintains the stemness of chemotherapeutic drug-resistant leukemia cells by inhibiting senescence and cytotoxic T lymphocyte-mediated killing in a ubiquitinated degradation manner. J Exp Clin Cancer Res. 2025;44(1):170. https:\/\/doi.org\/10.1186\/s13046-025-03420-9.","journal-title":"J Exp Clin Cancer Res"},{"issue":"4","key":"3128_CR8","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1039\/d3fo05484e","volume":"15","author":"J Li","year":"2024","unstructured":"Li J, Zhao J, Wang X, et al. Ginsenoside - a promising natural active ingredient with steroidal hormone activity. Food Funct. 2024;15(4):1825\u201339. https:\/\/doi.org\/10.1039\/d3fo05484e.","journal-title":"Food Funct"},{"issue":"10","key":"3128_CR9","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.3390\/ph18101529","volume":"18","author":"CE Hong","year":"2025","unstructured":"Hong CE, Lyu SY. Immunomodulatory activities of emerging rare ginsenosides F1, Rg5, Rk1, Rh1, and Rg2: from molecular mechanisms to therapeutic applications. Pharmaceuticals (Basel). 2025;18(10):1529. https:\/\/doi.org\/10.3390\/ph18101529.","journal-title":"Pharmaceuticals (Basel)"},{"key":"3128_CR10","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.biopha.2016.11.112","volume":"85","author":"S Patel","year":"2017","unstructured":"Patel S, Rauf A. Adaptogenic herb ginseng (Panax) as medical food: status quo and future prospects. Biomed Pharmacother. 2017;85:120\u20137. https:\/\/doi.org\/10.1016\/j.biopha.2016.11.112.","journal-title":"Biomed Pharmacother"},{"issue":"Pt B","key":"3128_CR11","doi-asserted-by":"publisher","first-page":"120666","DOI":"10.1016\/j.jep.2025.120666","volume":"355","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Liu Y, Wei Y, et al. The role of rare ginsenosides in the prevention and treatment of liver diseases. J Ethnopharmacol. 2025;355(Pt B):120666. https:\/\/doi.org\/10.1016\/j.jep.2025.120666.","journal-title":"J Ethnopharmacol"},{"key":"3128_CR12","doi-asserted-by":"publisher","first-page":"156516","DOI":"10.1016\/j.phymed.2025.156516","volume":"140","author":"L Zhang","year":"2025","unstructured":"Zhang L, Zhao XL, Cao ZJ, et al. Ginsenoside CK inhibits EMT and overcomes oxaliplatin resistance in gastric cancer by targeting the PI3K\/Akt pathway. Phytomedicine. 2025;140:156516. https:\/\/doi.org\/10.1016\/j.phymed.2025.156516.","journal-title":"Phytomedicine"},{"issue":"3","key":"3128_CR13","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.jgr.2021.07.004","volume":"46","author":"H Zhang","year":"2022","unstructured":"Zhang H, Yi JK, Huang H, et al. 20 (S)-ginsenoside Rh2 inhibits colorectal cancer cell growth by suppressing the Axl signaling pathway in vitro and in vivo. J Ginseng Res. 2022;46(3):396\u2013407. https:\/\/doi.org\/10.1016\/j.jgr.2021.07.004.","journal-title":"J Ginseng Res"},{"key":"3128_CR14","doi-asserted-by":"publisher","first-page":"117158","DOI":"10.1016\/j.taap.2024.117158","volume":"494","author":"Z Deng","year":"2025","unstructured":"Deng Z, Ou M, Shi Y, et al. Ginsenoside Rg3 attenuates the stemness of breast cancer stem cells by activating the Hippo signaling pathway. Toxicol Appl Pharmacol. 2025;494:117158. https:\/\/doi.org\/10.1016\/j.taap.2024.117158.","journal-title":"Toxicol Appl Pharmacol"},{"issue":"1","key":"3128_CR15","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.jgr.2020.02.005","volume":"45","author":"H Kim","year":"2021","unstructured":"Kim H, Choi P, Kim T, et al. Ginsenosides Rk1 and Rg5 inhibit transforming growth factor-\u03b21-induced epithelial-mesenchymal transition and suppress migration, invasion, Anoikis resistance, and development of stem-like features in lung cancer. J Ginseng Res. 2021;45(1):134\u201348. https:\/\/doi.org\/10.1016\/j.jgr.2020.02.005.","journal-title":"J Ginseng Res"},{"issue":"6","key":"3128_CR16","doi-asserted-by":"publisher","first-page":"599","DOI":"10.17219\/acem\/133485","volume":"30","author":"YL Tang","year":"2021","unstructured":"Tang YL, Wang XB, Zhou Y, et al. Ginsenoside Rg1 induces senescence of leukemic stem cells by upregulating p16INK4a and downregulating hTERT expression. Adv Clin Exp Med. 2021;30(6):599\u2013605. https:\/\/doi.org\/10.17219\/acem\/133485.","journal-title":"Adv Clin Exp Med"},{"key":"3128_CR17","doi-asserted-by":"publisher","DOI":"10.1080\/14786419.2024.2440537","author":"B Geng","year":"2024","unstructured":"Geng B, Zhao M, Wang J, et al. Ginsenoside Rh2 promotes cell apoptosis in T-cell acute lymphoblastic leukaemia by MAPK and PI3K\/AKT signalling pathways. Nat Prod Res. 2024. https:\/\/doi.org\/10.1080\/14786419.2024.2440537.","journal-title":"Nat Prod Res"},{"issue":"12","key":"3128_CR18","doi-asserted-by":"publisher","first-page":"e12106","DOI":"10.1016\/j.heliyon.2022.e12106","volume":"8","author":"Y Hou","year":"2022","unstructured":"Hou Y, Meng X, Sun K, et al. Anti-cancer effects of ginsenoside CK on acute myeloid leukemia in vitro and in vivo. Heliyon. 2022;8(12):e12106. https:\/\/doi.org\/10.1016\/j.heliyon.2022.e12106.","journal-title":"Heliyon"},{"key":"3128_CR19","doi-asserted-by":"publisher","first-page":"105769","DOI":"10.1016\/j.fitote.2023.105769","volume":"172","author":"G Yang","year":"2024","unstructured":"Yang G, Gao Y, Gao L, et al. Increasing minor ginsenosides contents and enhancing neuroprotective effects of total ginsenosides fermented by Lactiplantibacillus plantarum. Fitoterapia. 2024;172:105769. https:\/\/doi.org\/10.1016\/j.fitote.2023.105769.","journal-title":"Fitoterapia"},{"key":"3128_CR20","doi-asserted-by":"publisher","unstructured":"Zhang Y, Ma P, Duan Z et al. Ginsenoside Rh4 suppressed metastasis of lung adenocarcinoma via inhibiting JAK2\/STAT3 signaling. Int J Mol Sci. 2022;23(4):2018. https:\/\/doi.org\/10.3390\/ijms23042018","DOI":"10.3390\/ijms23042018"},{"issue":"15","key":"3128_CR21","doi-asserted-by":"publisher","first-page":"3042","DOI":"10.3390\/nu14153042","volume":"14","author":"J Chen","year":"2022","unstructured":"Chen J, Duan Z, Liu Y, et al. Ginsenoside Rh4 suppresses metastasis of esophageal cancer and expression of c-Myc via targeting the Wnt\/\u03b2-Catenin signaling pathway. Nutrients. 2022;14(15):3042. https:\/\/doi.org\/10.3390\/nu14153042.","journal-title":"Nutrients"},{"issue":"6","key":"3128_CR22","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1007\/s00438-023-02070-w","volume":"298","author":"R Jiang","year":"2023","unstructured":"Jiang R, Luo S, Zhang M, et al. Ginsenoside Rh4 inhibits inflammation-related hepatocellular carcinoma progression by targeting HDAC4\/IL-6\/STAT3 signaling. Mol Genet Genomics. 2023;298(6):1479\u201392. https:\/\/doi.org\/10.1007\/s00438-023-02070-w.","journal-title":"Mol Genet Genomics"},{"key":"3128_CR23","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.mce.2017.02.023","volume":"451","author":"R Lu","year":"2017","unstructured":"Lu R, Zhang YG, Sun J. STAT3 activation in infection and infection-associated cancer. Mol Cell Endocrinol. 2017;451:80\u20137. https:\/\/doi.org\/10.1016\/j.mce.2017.02.023.","journal-title":"Mol Cell Endocrinol"},{"key":"3128_CR24","doi-asserted-by":"publisher","first-page":"117449","DOI":"10.1016\/j.taap.2025.117449","volume":"502","author":"PT Cheng","year":"2025","unstructured":"Cheng PT, Lin H, Cheng YC, et al. Alisertib inhibits acute myeloid leukemia cell growth by inhibiting STAT3 activation. Toxicol Appl Pharmacol. 2025;502:117449. https:\/\/doi.org\/10.1016\/j.taap.2025.117449.","journal-title":"Toxicol Appl Pharmacol"},{"key":"3128_CR25","doi-asserted-by":"publisher","first-page":"144818","DOI":"10.1016\/j.ijbiomac.2025.144818","volume":"317","author":"J Qiu","year":"2025","unstructured":"Qiu J, Xu J, Zhang J, et al. Exploring the mechanism by which BXSD decoction treats cervical cancer through the combination of network pharmacology and molecular docking analysis: molecular mechanism of AKT1 and CASP3 protein. Int J Biol Macromol. 2025;317:144818. https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.144818.","journal-title":"Int J Biol Macromol"},{"key":"3128_CR26","doi-asserted-by":"publisher","first-page":"156441","DOI":"10.1016\/j.phymed.2025.156441","volume":"139","author":"Y Li","year":"2025","unstructured":"Li Y, Dong M, Qin H, et al. Mulberrin suppresses gastric cancer progression and enhances chemosensitivity to oxaliplatin through HSP90AA1\/PI3K\/AKT axis. Phytomedicine. 2025;139:156441. https:\/\/doi.org\/10.1016\/j.phymed.2025.156441.","journal-title":"Phytomedicine"},{"key":"3128_CR27","doi-asserted-by":"publisher","first-page":"102148","DOI":"10.1016\/j.tranon.2024.102148","volume":"50","author":"Z Wang","year":"2024","unstructured":"Wang Z, Fan L, Xu H, et al. HSP90AA1 is an unfavorable prognostic factor for hepatocellular carcinoma and contributes to tumorigenesis and chemotherapy resistance. Transl Oncol. 2024;50:102148. https:\/\/doi.org\/10.1016\/j.tranon.2024.102148.","journal-title":"Transl Oncol"},{"issue":"2","key":"3128_CR28","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1158\/1078-0432.CCR-12-2087","volume":"19","author":"HJ Lee","year":"2013","unstructured":"Lee HJ, Daver N, Kantarjian HM, et al. The role of JAK pathway dysregulation in the pathogenesis and treatment of acute myeloid leukemia. Clin Cancer Res. 2013;19(2):327\u201335. https:\/\/doi.org\/10.1158\/1078-0432.CCR-12-2087.","journal-title":"Clin Cancer Res"},{"key":"3128_CR29","doi-asserted-by":"publisher","first-page":"1483896","DOI":"10.3389\/fphar.2024.1483896","volume":"15","author":"R Ding","year":"2025","unstructured":"Ding R, Kan Q, Wang T, et al. Ginsenoside Rh2 regulates triple-negative breast cancer proliferation and apoptosis via the IL-6\/JAK2\/STAT3 pathway. Front Pharmacol. 2025;15:1483896. https:\/\/doi.org\/10.3389\/fphar.2024.1483896.","journal-title":"Front Pharmacol"},{"key":"3128_CR30","doi-asserted-by":"publisher","first-page":"154015","DOI":"10.1016\/j.phymed.2022.154015","volume":"99","author":"Y Zuo","year":"2022","unstructured":"Zuo Y, Zhang CZ, Ren Q, et al. Activation of mitochondrial-associated apoptosis signaling pathway and Inhibition of PI3K\/Akt\/mTOR signaling pathway by voacamine suppress breast cancer progression. Phytomedicine. 2022;99:154015. https:\/\/doi.org\/10.1016\/j.phymed.2022.154015.","journal-title":"Phytomedicine"},{"issue":"9","key":"3128_CR31","doi-asserted-by":"publisher","first-page":"2934","DOI":"10.3390\/jcm9092934","volume":"9","author":"S Darici","year":"2020","unstructured":"Darici S, Alkhaldi H, Horne G, et al. Targeting PI3K\/Akt\/mTOR in AML: rationale and clinical evidence. J Clin Med. 2020;9(9):2934. https:\/\/doi.org\/10.3390\/jcm9092934.","journal-title":"J Clin Med"},{"key":"3128_CR32","doi-asserted-by":"publisher","first-page":"112582","DOI":"10.1016\/j.ejmech.2020.112582","volume":"203","author":"T Xia","year":"2020","unstructured":"Xia T, Zhang B, Li Y, et al. New insight into 20(S)-ginsenoside Rh2 against T-cell acute lymphoblastic leukemia associated with the gut microbiota and the immune system. Eur J Med Chem. 2020;203:112582. https:\/\/doi.org\/10.1016\/j.ejmech.2020.112582.","journal-title":"Eur J Med Chem"},{"key":"3128_CR33","doi-asserted-by":"publisher","first-page":"669363","DOI":"10.3389\/fcell.2021.669363","volume":"9","author":"ES Fasouli","year":"2021","unstructured":"Fasouli ES, Katsantoni E. JAK-STAT in early hematopoiesis and leukemia. Front Cell Dev Biol. 2021;9:669363. https:\/\/doi.org\/10.3389\/fcell.2021.669363.","journal-title":"Front Cell Dev Biol"},{"key":"3128_CR34","doi-asserted-by":"publisher","first-page":"100634","DOI":"10.1016\/j.blre.2019.100634","volume":"40","author":"S Venugopal","year":"2020","unstructured":"Venugopal S, Bar-Natan M, Mascarenhas JO. JAKs to stats: A tantalizing therapeutic target in acute myeloid leukemia. Blood Rev. 2020;40:100634. https:\/\/doi.org\/10.1016\/j.blre.2019.100634.","journal-title":"Blood Rev"},{"key":"3128_CR35","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.jep.2016.08.039","volume":"194","author":"S Han","year":"2016","unstructured":"Han S, Jeong AJ, Yang H, et al. Ginsenoside 20(S)-Rh2 exerts anti-cancer activity through targeting IL-6-induced JAK2\/STAT3 pathway in human colorectal cancer cells. J Ethnopharmacol. 2016;194:83\u201390. https:\/\/doi.org\/10.1016\/j.jep.2016.08.039.","journal-title":"J Ethnopharmacol"},{"key":"3128_CR36","doi-asserted-by":"publisher","first-page":"110634","DOI":"10.1016\/j.cbi.2023.110634","volume":"382","author":"MA Shah","year":"2023","unstructured":"Shah MA, Abuzar SM, Ilyas K, et al. Ginsenosides in cancer: targeting cell cycle arrest and apoptosis. Chem Biol Interact. 2023;382:110634. https:\/\/doi.org\/10.1016\/j.cbi.2023.110634.","journal-title":"Chem Biol Interact"},{"key":"3128_CR37","doi-asserted-by":"publisher","first-page":"156859","DOI":"10.1016\/j.phymed.2025.156859","volume":"143","author":"Y Cao","year":"2025","unstructured":"Cao Y, Wang Y, Chen Y, et al. Voacamine initiates the PI3K\/mTOR\/Beclin1 pathway to induce autophagy and potentiate apoptosis in acute myeloid leukemia. Phytomedicine. 2025;143:156859. https:\/\/doi.org\/10.1016\/j.phymed.2025.156859.","journal-title":"Phytomedicine"},{"key":"3128_CR38","doi-asserted-by":"publisher","first-page":"100978","DOI":"10.1016\/j.crfs.2025.100978","volume":"10","author":"P Yu","year":"2025","unstructured":"Yu P, Xu W, Li Y, et al. Ginsenosides 20R-Rg3 and Rg5 enriched black ginseng inhibits colorectal cancer tumor growth by activating the Akt\/Bax\/caspase-3 pathway and modulating gut microbiota in mice. Curr Res Food Sci. 2025;10:100978. https:\/\/doi.org\/10.1016\/j.crfs.2025.100978.","journal-title":"Curr Res Food Sci"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-025-03128-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12032-025-03128-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-025-03128-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T03:50:21Z","timestamp":1769485821000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12032-025-03128-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,20]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1]]}},"alternative-id":["3128"],"URL":"https:\/\/doi.org\/10.1007\/s12032-025-03128-y","relation":{},"ISSN":["1559-131X"],"issn-type":[{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,20]]},"assertion":[{"value":"25 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Institutional review board statement"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}],"article-number":"8"}}